BCM Press
Release: "RESTing
on a new approach to cancer" An
enzyme that marks a critical protein called REST for degradation
in the cell could provide an important target for the development
of new cancer treatments, said researchers from Baylor College
of Medicine and Harvard Medical School in the current issue of
the journal Nature...(read
more). For Nature paper: SCFb-TRCP controls
oncogenic transformation and neural differentiation through REST
degradation
The Darwin Transgenic Mouse Core Facility web
site has moved. The new link is: http://www.bcm.edu/dtmc/ Please
update your bookmarks.
The dup
17p11.2 GCRC and dup
7q11.23 GCRC protocols are now active and online.
The 2008 Molecular and Human Genetics Brochure is
now available for download.
You must have Adobe Acrobat Reader to view the file. You can navigate
through the file by click on the "bookmarks" tab.
|
